Phase 3 Readout~month

Phase 3 Topline: A Phase 2,Double-Blind,Randomized Clinical Trial to Explore the Safety,Tolerability,Efficacy, and Ph

Indication
SCN2A Encephalopathy; SCN8A Encephalopathy

Other upcoming events for PRAX

Phase 2 ReadoutPhase 2 Readout: relutrigine
Phase 2 ReadoutPhase 2 Readout: elsunersen
PDUFA DatePDUFA Date: relutrigine
Phase 3 ReadoutPhase 3 Topline: Phase 3, Decentralized, Randomized, Double-Blind, Placebo Controlled, Parallel Design, Randomized Wi
PDUFA DatePDUFA Date: ulixacaltamide hcl

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 2,Double-Blind,Randomized Clinical Trial to Explore the Safety,Tolerability,Efficacy, and Ph — PRAX Phase 3 Readout | BioSniper